Featured Research

from universities, journals, and other organizations

For Some Who Have Lost Their Sense Of Smell, A Once Popular Asthma Drug Could Help

Date:
April 9, 2008
Source:
American Physiological Society
Summary:
Some seven percent of Americans have lost their sense of smell and with it their ability to enjoy the fragrance of flowers, foods and beverages. For individuals whose smell loss relates to the biochemistry of two common proteins, there is some good news. A team of researchers has found that a drug used long ago to help asthmatics can benefit some with smell loss.

Despite the fact that millions of Americans are believed to have lost their sense of smell (hyposmia), no effective method exists to treat many of these people. That is due in part to the fact that the causes of smell loss are varied and complex, ranging from chronic allergies, viral infection, head injury, or no apparent reason at all. Some seven percent of Americans have lost their sense of smell and with it their ability to enjoy the fragrance of flowers, foods and beverages. For individuals whose smell loss relates to the biochemistry of two common proteins, there is some good news. A team of researchers has found that a drug used long ago to help asthmatics can benefit some with smell loss. 

The Study

The results are contained in a study entitled Effective Treatment of Smell Loss With Theophylline. It was conducted by Robert I. Henkin, Irina Velicu and Loren Schmidt all of the Taste and Smell Clinic, Center for Molecular Nutritional Sensory Disorders, Washington, DC. Dr. Henkin will present his team’s findings at the 121st annual meeting of the American Physiological Society, part of the Experimental Biology 2008 scientific conference.

A total of 369 individuals were enrolled in the study. Of the total, 314 had smell loss and 55 did not; 169 were female and 145 were male. The participants were 53 years of age ± 1 year. Smell loss was measured using standard testing procedures to determine the type, degree and character of smell loss. These included objective smell function (psychophysical) and subjective (quantitative evaluation of smell loss) methods. Blood measures and smell function were evaluated regularly throughout the study.

The researchers had previously discovered that decreased levels of two proteins – cyclic AMP (cAMP) and cyclic GMP (cGMP) – in nasal mucus inhibited growth and development of olfactory receptor cells and thus caused smell loss. For this reason, patients consumed 200, 400 or 600 mg of theophylline (correlated to blood levels) for a period of 2-6 months.

The drug theophylline is a generalized phosphodiesterase inhibitor. Physicians have determined that the drug is a generalized inhibitor which means it causes certain chemicals like cAMP and cGMP to increase. Thus, the higher the levels of cAMP the greater the ability to smell. This is true to a lesser extent for cGMP. It had been used widely in the l940s and 1950s for the treatment of asthma and has been shown to restore the biochemical problems associated with smell loss in recent years. It has not, however, been approved by the FDA for this purpose.

Results

At the end of the study the researchers found that:

  • Psychophysical measurements showed that smell function had increased for more than 70 percent of the participants.
  • Subjective measurements showed an increase in smelling ability for 47 percent of the participants.
  • No correlation in theophylline blood levels changes were evident between those whose smell loss improved and those whose smell level did not improve.
  • There were no significant differences in improvement based on gender or age.
  • When patients improved and stayed on the drug they continued to improve. Conversely, if they improved their ability to smell then stopped the drug they lost the gains they had made in their ability to smell. 

Conclusion

According to Dr. Henkin, “It is well known that millions of Americans have smell loss. It is less well known that many of these patients have lower than normal levels of cAMP and cGMP and that theophylline is useful to them since it increases the proteins in the mucus levels of their nasal passages.” He continued, “These findings do not relate to all patients with smell loss but to the many who have this biochemical abnormality. In a similar vein, treatment of patients with high cholesterol with cholesterol lowering agents is useful in treatment of heart disease, but there are many causes of heart disease besides elevated cholesterol.”


Story Source:

The above story is based on materials provided by American Physiological Society. Note: Materials may be edited for content and length.


Cite This Page:

American Physiological Society. "For Some Who Have Lost Their Sense Of Smell, A Once Popular Asthma Drug Could Help." ScienceDaily. ScienceDaily, 9 April 2008. <www.sciencedaily.com/releases/2008/04/080407114619.htm>.
American Physiological Society. (2008, April 9). For Some Who Have Lost Their Sense Of Smell, A Once Popular Asthma Drug Could Help. ScienceDaily. Retrieved August 29, 2014 from www.sciencedaily.com/releases/2008/04/080407114619.htm
American Physiological Society. "For Some Who Have Lost Their Sense Of Smell, A Once Popular Asthma Drug Could Help." ScienceDaily. www.sciencedaily.com/releases/2008/04/080407114619.htm (accessed August 29, 2014).

Share This




More Mind & Brain News

Friday, August 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Treadmill 'trips' May Reduce Falls for Elderly

Treadmill 'trips' May Reduce Falls for Elderly

AP (Aug. 28, 2014) — Scientists are tripping the elderly on purpose in a Chicago lab in an effort to better prevent seniors from falling and injuring themselves in real life. (Aug.28) Video provided by AP
Powered by NewsLook.com
Alice in Wonderland Syndrome

Alice in Wonderland Syndrome

Ivanhoe (Aug. 27, 2014) — It’s an unusual condition with a colorful name. Kids with “Alice in Wonderland” syndrome see sudden distortions in objects they’re looking at or their own bodies appear to change size, a lot like the main character in the Lewis Carroll story. Video provided by Ivanhoe
Powered by NewsLook.com
Stopping Schizophrenia Before Birth

Stopping Schizophrenia Before Birth

Ivanhoe (Aug. 27, 2014) — Scientists have long called choline a “brain booster” essential for human development. Not only does it aid in memory and learning, researchers now believe choline could help prevent mental illness. Video provided by Ivanhoe
Powered by NewsLook.com
Personalized Brain Vaccine for Glioblastoma

Personalized Brain Vaccine for Glioblastoma

Ivanhoe (Aug. 27, 2014) — Glioblastoma is the most common and aggressive brain cancer in humans. Now a new treatment using the patient’s own tumor could help slow down its progression and help patients live longer. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins